Urothelial lesions with inverted growth patterns: Histogenesis, molecular genetic findings, differential diagnosis and clinical management

BJU International

Volumn 107, Issue 4, 2011, Pages 532-537

  Hodges, Kurt B ^a   Lopez Beltran, Antonio ^c   MacLennan, Gregory T ^a,b   Montironi, Rodolfo ^d   Cheng, Liang ^a  

^a INDIANA UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CÓRDOBA   (Spain)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

differential diagnosis; fibroblast growth factor receptor 3 (FGFR3); histological variant; inverted and nested TCC urothelial carcinoma; molecular genetics; molecular pathology; precursor lesions; transitional cell (urothelial) carcinoma; tumourigenesis(carcinogenesis); urinary bladder; urothelial papilloma

Indexed keywords

CD20 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; BLADDER INJURY; BLADDER PAPILLOMA; CELL PROLIFERATION; CELL SUBPOPULATION; CHROMOSOME ABERRATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CYSTECTOMY; CYSTITIS; CYSTITIS CYSTICA; CYSTITIS GRANDULARIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HISTOGENESIS; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; VERRUCOUS CARCINOMA; X CHROMOSOME INACTIVATION;

CARCINOMA, TRANSITIONAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; PAPILLOMA, INVERTED; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 78650707969     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09853.x     Document Type: Article

References (36)

1. Cheng L, Lopez-Beltran A, MacLennan GT, Montironi R, Bostwick DG,. Neoplasms of the urinary bladder. In, Bostwick DG, Cheng L, eds. Urologic Surgical Pathology, 2nd edn. Philadelphia: Elsevier/Mosby, 2008: 259-352
2. Sung MT, MacLennan GT, Lopez-Beltran A, Montironi R, Cheng L,. Natural history of urothelial inverted papilloma. Cancer 2006; 107: 2622-7
3. Eble JN, Epstein JI, Sauter G, Sesterhenn I,. WHO Classification of Tumours: Pathology and Genetics. Tumours of the Urinary and Male Reproductive System. Lyon, France: IARC Press, 2004
4. Kunze E, Schauer A, Schmitt M,. Histology and histogenesis of two different types of inverted urothelial papillomas. Cancer 1983; 51: 348-58
5. Cheng CW, Chan LW, Chan CK, et al. Is surveillance necessary for inverted papilloma in the urinary bladder and urethra? ANZ J Surg 2005; 75: 213-7
6. Rozanski TA,. Inverted papilloma: an unusual recurrent, multiple and multifocal lesion. J Urol 1996; 155: 1391
7. Summers DE, Rushin JM, Frazier HA, Cotelingam JD,. Inverted papilloma of the urinary bladder with granular eosinophilic cells. An unusual neuroendocrine variant. Published erratum appears in Arch Pathol Lab Med 1991 Dec;115(12):1194. Arch Pathol Lab Med 1991; 115: 802-6
8. Broussard JN, Tan PH, Epstein JI,. Atypia in inverted urothelial papillomas: pathology and prognostic significance. Hum Pathol 2004; 35: 1499-504
9. Fine SW, Epstein JI,. Inverted urothelial papillomas with foamy or vacuolated cytoplasm. Hum Pathol 2006; 37: 1577-82
10. Albores-Saavedra J, Chable-Montero F, Hernandez-Rodriguez OX, Montante-Montes de Oca D, Angeles-Angeles A,. Inverted urothelial papilloma of the urinary bladder with focal papillary pattern: a previously undescribed feature. Ann Diagn Pathol 2009; 13: 158-61
11. Asano K, Miki J, Maeda S, Naruoka T, Takahashi H, Oishi Y,. Clinical studies on inverted papilloma of the urinary tract: report of 48 cases and review of the literature. J Urol 2003; 170: 1209-12 (Pubitemid 37108114)
12. Altaffer LF III, Wilkerson SY, Jordan GH, Lynch DF,. Malignant inverted papilloma and carcinoma in situ of the bladder. J Urol 1982; 128: 816-8
13. Cheville JC, Wu K, Sebo TJ, et al. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma? Cancer 2000; 88: 632-6
14. Sung MT, Eble JN, Wang M, Tan PH, Lopez-Beltran A, Cheng L,. Inverted papilloma of the urinary bladder: a molecular genetic appraisal. Mod Pathol 2006; 19: 1289-94
15. Eiber M, van Oers JM, Zwarthoff EC, et al. Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract. Am J Surg Pathol 2007; 31: 938-46
16. Junker K, Boerner D, Schulze W, Utting M, Schubert J, Werner W,. Analysis of genetic alterations in normal bladder urothelium. Urology 2003; 62: 1134-8
17. Lott S, Wang M, Zhang S, et al. FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations. Mod Pathol 2009; 22: 627-32
18. Amin MB, Gomez JA, Young RH,. Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 1997; 21: 1057-68
19. Goldstein AM, Fauer RB, Chinn M, Kaempf MJ,. New concepts on formation of Brunn's nests and cysts in urinary tract mucosa. Urology 1978; 11: 513-7
20. Ito N, Hirose M, Shirai T, Tsuda H, Nakanishi K, Fukushima S,. Lesions of the urinary bladder epithelium in 125 autopsy cases. Acta Pathol Jpn 1981; 31: 545-57
21. Andersen JA, Hansen BF,. The incidence of cell nests, cystitis cystica and cystitis glandularis in the lower urinary tract revealed by autopsies. J Urol 1972; 108: 421-4
22. Volmar KE, Chan TY, De Marzo AM, Epstein JI,. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma. Am J Surg Pathol 2003; 27: 1243-52
23. Young RH, Bostwick DG,. Florid cystitis glandularis of intestinal type with mucin extravasation: a mimic of adenocarcinoma. Am J Surg Pathol 1996; 20: 1462-8
24. Jacobs LB, Brooks JD, Epstein JI,. Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder. Hum Pathol 1997; 28: 1152-7
25. Smith AK, Hansel DE, Jones JS,. Role of cystitis cystica et glandularis and intestinal metaplasia in development of bladder carcinoma. Urology 2008; 71: 915-8
26. Corica FA, Husmann DA, Churchill BM, et al. Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up. Urology 1997; 50: 427-31
27. Cameron KM, Lupton CH,. Inverted papilloma of the lower urinary tract. Br J Urol 1976; 48: 567-77
28. Talbert ML, Young RH,. Carcinomas of the urinary bladder with deceptively benign-appearing foci. A report of three cases. Am J Surg Pathol 1989; 13: 374-81
29. Jones TD, Zhang S, Lopez-Beltran A, et al. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol 2007; 31: 1861-7
30. Lopez-Beltran A, Cheng L,. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol 2006; 37: 1371-88
31. Holmang S, Johansson SL,. The nested variant of transitional cell carcinoma-a rare neoplasm with poor prognosis. Scand J Urol Nephrol 2001; 35: 102-5
32. Drew PA, Furman J, Civantos F, Murphy WM,. The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol 1996; 9: 989-94
33. Boxer RJ, Skinner DG,. Condylomata acuminata and squamous cell carcinoma. Urology 1977; 9: 72-8
34. El Sebai I, Sherif M, El Bolkainy MN, Mansour MA, Ghoneim MA,. Verrucous squamous carcinoma of bladder. Urology 1974; 4: 407-10
35. El-Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussein MH,. The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer 1981; 48: 2643-8
36. Cheng L, Leibovich BC, Cheville JC, et al. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer 2000; 88: 1679-86